An Extension Study of EV-BR1701 Part A1

Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers

NCT00667602 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

NCT06617715 ·Status: RECRUITING ·Phase: PHASE3

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan

NCT01410474 ·Status: COMPLETED ·Phase: PHASE3

PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae

NCT02133469 ·Status: COMPLETED ·Phase: NA

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

NCT00310856 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents

NCT06838000 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Immunogenicity of SA 14-14-2 JE Vaccine

NCT01635816 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

NCT02692599 ·Status: COMPLETED ·Phase: PHASE3

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

NCT01823536 ·Status: COMPLETED ·Phase: PHASE4

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

NCT07348692 ·Status: RECRUITING ·Phase: PHASE3

Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

NCT00734565 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Prevenar Vaccine in Healthy Infants

NCT00276107 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

NCT00475033 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®

NCT00488371 ·Status: COMPLETED

Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

NCT07135986 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants

NCT00433914 ·Status: COMPLETED ·Phase: PHASE2

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

NCT01717638 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers

NCT04357522 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

NCT00474526 ·Status: COMPLETED ·Phase: PHASE3

Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)

NCT00092469 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

NCT00753649 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults

NCT05952596 ·Status: UNKNOWN ·Phase: PHASE1

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

NCT03691610 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

NCT00366340 ·Status: COMPLETED ·Phase: PHASE3

Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers

NCT00847145 ·Status: COMPLETED ·Phase: PHASE3